Blog

Vikram M. Narayan: New findings on MRD detection in urinary DNA for NMIBC

Vikram M. Narayan/X

Oct 25, 2024, 16:11

Vikram M. Narayan: New findings on MRD detection in urinary DNA for NMIBC

Vikram M. Narayan, Urologic Cancer Surgeon at GradyHealth, shared a post on X:

“New findings on MRD detection in urinary DNA for BCG Unresponsive NMIBC!

Using Convergent Genomics UroAmp test, we:

• Prognosticate 12-mo RFS post Nadofaragene (Adstiladrin)
• Characterize utDNA changes over time.”

Vikram M. Narayan

Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec

Authors: Vikram M. Narayan, Come Tholomier, Sharada Mokkapati, Alberto Martini, Vincent M. Caruso, Mahdi Goudarzi, Brian C. Mazzarella, Kevin G. Phillips, Vincent T. Bicocca, Trevor G. Levin, Seppo Yla-Herttuala, David J. McConkey and Colin P.N. Dinney.

Vikram M. Narayan

Alberto Martini Brian C. Mazzarella cancer cancer awareness cancer care Colin P.N. Dinney Come Tholomier Convergent Genomics David J. McConkey fight against cancer Global fight against cancer Kevin G. Phillips Mahdi Goudarzi NMIBC OncoDaily Oncology Seppo Yla-Herttuala Sharada Mokkapati Trevor G. Levin Vikram M. Narayan Vincent M. Caruso Vincent T. Bicocca

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology